Related Experiment Video
Updated: Jun 29, 2026
08:45
Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 26, 2016
New type sedative and soporific drug
Science (New York, N.Y.)
|December 19, 1958
Summary
Trimethoxybenzoyl-glycine-diethylamide induced normal sleep in animals. Higher doses caused agitation, while human trials showed sedation or drowsiness, with no electroencephalographic abnormalities observed.
Area of Science:
- Pharmacology
- Neuroscience
- Veterinary Medicine
Background:
- Investigating novel sedative compounds is crucial for therapeutic applications.
- Understanding the dose-dependent effects of sedative agents is essential for safety and efficacy.
Purpose of the Study:
- To evaluate the sedative and behavioral effects of Trimethoxybenzoyl-glycine-diethylamide in animal models and humans.
- To assess the electroencephalographic (EEG) impact of Trimethoxybenzoyl-glycine-diethylamide.
Main Methods:
- Administered Trimethoxybenzoyl-glycine-diethylamide to dogs and cats to observe sleep and behavioral responses.
- Tested oral doses in human subjects and monitored for sedation or drowsiness.
- Performed electroencephalographic recordings during administration in human subjects.
Main Results:
- Normal sleep was induced in dogs and cats at therapeutic doses without ataxia.
- Increased doses in animals led to restlessness and disorientation, not sleep.
- Human subjects experienced sedation or drowsiness at oral doses of 500-1500 mg in 50% of cases.
- No spindling or drug-induced artifacts were detected in human EEG recordings.
Conclusions:
- Trimethoxybenzoyl-glycine-diethylamide exhibits dose-dependent sedative effects in animals and humans.
- The compound appears safe for electroencephalographic monitoring, showing no adverse EEG findings.
- Further research may explore its therapeutic potential as a sedative agent.
Keywords:
HYPNOTICS AND SEDATIVES
Related Concept Videos
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...